Background: Racial/ethnic minorities have among the highest risks for Alzheimer disease
and dementia, but remain underrepresented in clinical research studies. Objective: To …

Abstract The Alzheimer's Association and National Institutes of Health have emphasized the
need for participation of racial/ethnic populations in Alzheimer disease (AD) clinical …

Introduction Alzheimer's disease and related dementias (ADRD) disproportionately impact
racial and ethnic minority and socioeconomically disadvantaged adults. Yet, these …

Abstract Background/Aims: The recruitment of culturally diverse subject populations into
research studies, particularly African-Americans (AA), has been the focus of intense interest …

Introduction Ethnicity influences dementia etiology, prognosis, and treatment, while culture
shapes help‐seeking and care. Despite increasing population diversity in high‐income …

Despite an increasing awareness of the problem, clinical research continues to include
lesser numbers of ethnic minority participants disproportionate to their population …

We describe the history, development, and success of the recruitment and screening
procedures used by researchers at the University of California, Davis Alzheimer's Disease …

African Americans experience higher incidence and prevalence of Alzheimer's disease
(AD). Yet, they continue to be underrepresented in AD research, limiting the ability to …

Despite older racial and ethnic minorities (REMs) being more likely to develop dementia
they are underrepresented in clinical trials focused on neurological disorders. Inclusion of …

This study reviews the published literature on racial and ethnic disparities among people
with Alzheimer's disease (AD) and related dementias in the United States. To identify …